Stephen L Lemieux Insider Profile
4 Followers
Stephen L Lemieux, President at Neupath Health Inc., holds 233.80K shares in Neupath Health Inc. (Ticker: TSE:NPTH), holds 17.40K shares in Edesa Biotech (Ticker: EDSA), holds 19.77K shares in Cipher Pharmaceuticals (Ticker: CPHRF). Most recently, Stephen L Lemieux Bought ― shares of Neupath Health Inc. on May 20, 2026 for an estimated value of C$2.78K.
Stephen L Lemieux Neupath Health Inc. (NPTH)President
Neupath Health Inc. (NPTH)
President
Ranked #7,421 out of 109,030 Corporate Insiders
Profitable Transactions
6 out of 8 Profitable Transactions
Average Return
+33.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen L Lemieux holds in companies
Most Profitable Insider Trade
Stock:
Nuvo Pharmaceuticals
(MRV)
(MRV)
Rating:Informative Buy
Date:Apr 03, 2014 - Apr 03, 2015
Return:+159.20%
The most profitable trade made by Stephen L Lemieux
Stephen L Lemieux's Trading History
Neupath Health Inc.
May 20, 2026
President
Informative Buy
2.78K
C$119.24K
Edesa Biotech
―
Chief Financial Officer
―
$71.95K
Cipher Pharmaceuticals
Jul 06, 2018
Chief Financial Officer & Secretary
Uninformative Sell
―
$209.75K
Nuvo Pharmaceuticals
Dec 15, 2015
―
Uninformative Sell
18.23K
C$28.24K
List of latest transactions for each holding click on a transaction to see Stephen L Lemieux's performance on stock
You May Also Like
Stephen L Lemieux insider profile FAQ
What is the percentage of profitable transactions made by Stephen L Lemieux?
The percentage of profitable transactions made by Stephen L Lemieux is 75%.
What is the average return per transaction made by Stephen L Lemieux?
The average return per transaction made by Stephen L Lemieux is 33.30%.
What stocks does Stephen L Lemieux hold?
Stephen L Lemieux holds: TSE:NPTH, EDSA, CPHRF, ~TSE:MRV stocks.
What was Stephen L Lemieux’s latest transaction?
Stephen L Lemieux latest transaction was an Informative Buy of C$2.78K.
What was Stephen L Lemieux's most profitable transaction?
Stephen L Lemieux’s most profitable transaction was an Informative Buy of ~TSE:MRV stock on April 3, 2014. The return on the trade was 159.20%.
What is Stephen L Lemieux's role in Neupath Health Inc.?
Stephen L Lemieux's role in Neupath Health Inc. is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.